Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD QOL in early Parkinson's Disease
NCT04590612Unknown
- Sponsor
- Western University
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of citalopram in Parkinson's disease (PD) and major depressive disorder (MDD) (2 arms), sponsored by Western University. Primary endpoint: Change in Short Form-36 at 6 months. Status: unknown.
02
Drugs
citalopram
03
Conditions
Parkinson's disease (PD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04590612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04590612.